Genelux Other Current Liab from 2010 to 2024

GNLX Stock   2.69  0.20  8.03%   
Genelux Common Other Current Liabilities yearly trend continues to be fairly stable with very little volatility. Other Current Liabilities will likely drop to about 1.4 M in 2024. During the period from 2010 to 2024, Genelux Common Other Current Liabilities regression line of annual values had r-squared of  0.59 and arithmetic mean of  8,376,253. View All Fundamentals
 
Other Current Liabilities  
First Reported
2010-12-31
Previous Quarter
1.5 M
Current Value
1.4 M
Quarterly Volatility
3.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Genelux Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genelux Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 883.5 K, Interest Expense of 4.2 M or Other Operating Expenses of 16.8 M, as well as many indicators such as Price To Sales Ratio of 2.1 K, Dividend Yield of 0.0 or PTB Ratio of 18.45. Genelux financial statements analysis is a perfect complement when working with Genelux Common Valuation or Volatility modules.
  
Check out the analysis of Genelux Common Correlation against competitors.
For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.

Latest Genelux Common's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Genelux Common over the last few years. It is Genelux Common's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genelux Common's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Genelux Other Current Liab Regression Statistics

Arithmetic Mean8,376,253
Geometric Mean7,278,298
Coefficient Of Variation36.59
Mean Deviation2,322,329
Median10,118,000
Standard Deviation3,064,700
Sample Variance9.4T
Range8.7M
R-Value(0.77)
Mean Square Error4.2T
R-Squared0.59
Significance0.0009
Slope(525,498)
Total Sum of Squares131.5T

Genelux Other Current Liab History

20241.4 M
20231.5 M
20227.8 M
2021M
20206.9 M

About Genelux Common Financial Statements

Genelux Common investors use historical fundamental indicators, such as Genelux Common's Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Genelux Common. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Liabilities1.5 M1.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Genelux Stock Analysis

When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.